His scientific interests lie mostly in Immunology, Viral load, Genetics, Allele and Genome-wide association study. His Immunology study focuses mostly on Hepatitis C, Ribavirin, Hepatitis C virus, Immune system and Interferon. His Viral load study incorporates themes from Human leukocyte antigen, MHC class I and Genotype.
His work on Genome and Gene as part of general Genetics research is often related to Set and Interface, thus linking different fields of science. His Genome-wide association study study integrates concerns from other disciplines, such as Human genetic variation, Genetic variation and Genetic association. His study looks at the relationship between Interleukin 28B and topics such as Gastroenterology, which overlap with Internal medicine, Telaprevir, Boceprevir and Pharmacogenetics.
His primary scientific interests are in Genetics, Immunology, Virology, Genome-wide association study and Viral load. As part of his studies on Genetics, he frequently links adjacent subjects like Disease. He focuses mostly in the field of Immunology, narrowing it down to topics relating to Internal medicine and, in certain cases, Oncology.
His Genome-wide association study research is multidisciplinary, incorporating perspectives in Host, Genetic variation and Genetic association. His studies in Viral load integrate themes in fields like T cell, Genotype and Heritability. His Single-nucleotide polymorphism research is multidisciplinary, incorporating elements of Cohort and Copy-number variation.
Jacques Fellay mostly deals with Internal medicine, Genetics, Genome, Human genetic variation and Virus. His Genome research integrates issues from Pathogen, Computational biology and Genetic association. His research on Human genetic variation also deals with topics like
His Virus study combines topics from a wide range of disciplines, such as Gene and Human virome. Jacques Fellay combines subjects such as Viral load and Major histocompatibility complex with his study of Human leukocyte antigen. Jacques Fellay works mostly in the field of Copy-number variation, limiting it down to topics relating to Genome-wide association study and, in certain cases, Genomics, as a part of the same area of interest.
His main research concerns Internal medicine, Human leukocyte antigen, Prospective cohort study, Genetics and Allele. The concepts of his Human leukocyte antigen study are interwoven with issues in Evolutionary biology, Genome-wide association study, Viral load and Major histocompatibility complex. His Viral load research is multidisciplinary, relying on both Proteome, Immune system, Cytotoxic T cell, Tapasin and Peptide.
His Prospective cohort study research incorporates elements of Exome sequencing, Sepsis, Pelvic inflammatory disease, Immunodeficiency and Primary immunodeficiency. Jacques Fellay undertakes multidisciplinary studies into Genetics and Mitochondrial Encephalomyopathies in his work. His study in Allele is interdisciplinary in nature, drawing from both Young adult, Interferon, Interferon type I, Immunity and Asymptomatic.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance.
Dongliang Ge;Jacques Fellay;Alexander J. Thompson;Jason S. Simon.
A Whole-Genome Association Study of Major Determinants for Host Control of HIV-1
Jacques Fellay;Kevin V. Shianna;Dongliang Ge;Sara Colombo.
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
Qian Zhang;Paul Bastard;Paul Bastard;Zhiyong Liu;Jérémie Le Pen.
Interleukin-28B Polymorphism Improves Viral Kinetics and Is the Strongest Pretreatment Predictor of Sustained Virologic Response in Genotype 1 Hepatitis C Virus
Alexander J. Thompson;Andrew J. Muir;Andrew J. Muir;Mark S. Sulkowski;Dongliang Ge.
Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study.
Jacques Fellay;Catia Marzolini;Emma R. Meaden;David J. Back.
The Lancet (2002)
ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C.
Jacques Fellay;Alexander J. Thompson;Dongliang Ge;Curtis E. Gumbs.
Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study
Jacques Fellay;Bruno Ledergerber;Enos Bernasconi;Hansjakob Furrer.
The Lancet (2001)
COVID-19 epidemic in Switzerland: on the importance of testing, contact tracing and isolation.
Marcel Salathé;Christian L Althaus;Richard Neher;Silvia Stringhini.
Swiss Medical Weekly (2020)
IL28B genotype is associated with differential expression of intrahepatic interferon‐stimulated genes in patients with chronic hepatitis C
Thomas J. Urban;Alexander J. Thompson;Shelton S. Bradrick;Jacques Fellay.
Common genetic variation and the control of HIV-1 in humans.
Jacques Fellay;Dongliang Ge;Kevin V. Shianna;Sara Colombo.
PLOS Genetics (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: